2AYR
A SERM Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus and Ovaries in Rats
2AYR の概要
| エントリーDOI | 10.2210/pdb2ayr/pdb |
| 分子名称 | Estrogen receptor, 6-(4-METHYLSULFONYL-PHENYL)-5-[4-(2-PIPERIDIN-1-YLETHOXY)PHENOXY]NAPHTHALEN-2-OL (3 entities in total) |
| 機能のキーワード | receptor, transcription, transcription regulation, ligand-binding, serm |
| 由来する生物種 | Homo sapiens (human) |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 28814.81 |
| 構造登録者 | Hummel, C.W.,Geiser, A.G.,Bryant, H.U.,Cohen, I.R.,Dally, R.D.,Fong, K.C.,Frank, S.A.,Hinklin, R.,Jones, S.A.,Lewis, G.,McCann, D.J.,Shepherd, T.A.,Tian, H.,Rudman, D.G.,Wallace, O.B.,Wang, Y.,Dodge, J.A. (登録日: 2005-09-07, 公開日: 2005-11-22, 最終更新日: 2023-08-23) |
| 主引用文献 | Hummel, C.W.,Geiser, A.G.,Bryant, H.U.,Cohen, I.R.,Dally, R.D.,Fong, K.C.,Frank, S.A.,Hinklin, R.,Jones, S.A.,Lewis, G.,McCann, D.J.,Rudman, D.G.,Shepherd, T.A.,Tian, H.,Wallace, O.B.,Wang, Y.,Dodge, J.A. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats J.Med.Chem., 48:6772-6775, 2005 Cited by PubMed Abstract: The design of a novel selective estrogen receptor modulator (SERM) for the potential treatment of uterine leiomyoma is described. 16 (LY2066948-HCl) binds with high affinity to estrogen receptors alpha and beta (ERalpha and ERbeta, respectively) and is a potent uterine antagonist with minimal effects on the ovaries as determined by serum biomarkers and histologic evaluation. PubMed: 16250633DOI: 10.1021/jm050723z 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.9 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






